MERCK SHARP & DOHME CORP recalls Cubicin (daptomycin for injection), 500 mg per vial, Single-dose vial, Rx only. Manuf. for: Merck Sharp & Dohme Corp., a
Recalled November 10, 2021 · FDA recall D-0093-2022 · MERCK SHARP & DOHME
Hazard
Presence of Particulate Matter: Identified as Glass Particles · FDA Class I
Units
76,163 vials
Sold at
Nationwide within the United States
Description
Presence of Particulate Matter: Identified as Glass Particles
Product
Cubicin (daptomycin for injection), 500 mg per vial, Single-dose vial, Rx only. Manuf. for: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ 08889, USA. Manuf. by: Baxter Pharmaceuticals LLC., Bloomington, IN 47403, USA, NDC: 67919-011-01
Manufacturer(s)
MERCK SHARP & DOHME CORP
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →